News by Tag: Us Nipd Sector
Clinical Trial Pipeline - Robust and Promising
January 8, 2013
The ongoing research pipeline for Non-Invasive Prenatal diagnostics (NIPD) is robust and will help in revealing promising results, says RNCOS.
January 8, 2013
The ongoing research pipeline for Non-Invasive Prenatal diagnostics (NIPD) is robust and will help in revealing promising results, says RNCOS.
Regulatory Framework for NIPD - Mixed Responses
November 6, 2012
"The Regulatory Framework for NIPD tests is weak and has generated varied responses amongst regulatory authorities, test developers, and end consumers", says RNCOS.
November 6, 2012
"The Regulatory Framework for NIPD tests is weak and has generated varied responses amongst regulatory authorities, test developers, and end consumers", says RNCOS.
Sequenom to Lead in the NIPD Market
September 3, 2012
Sequenom is expected to remain the undefeated market leader in the US NIPD market, says RNCOS.
September 3, 2012
Sequenom is expected to remain the undefeated market leader in the US NIPD market, says RNCOS.
US Non-Invasive Prenatal Diagnostics - Market Insight
August 13, 2012
RNCOS has recently added a new Market Research Report titled, "US Non-Invasive Prenatal Diagnostics - Market Insight" to its report gallery.
August 13, 2012
RNCOS has recently added a new Market Research Report titled, "US Non-Invasive Prenatal Diagnostics - Market Insight" to its report gallery.